Found 24 results
Author [ Title(Desc)] Type Year
Filters: Author is Blodi, Barbara A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
I. U. Scott, VanVeldhuisen, P. C., Oden, N. L., Ip, M. S., Blodi, B. A., J Jumper, M., and Figueroa, M., SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion., Ophthalmology, vol. 116, no. 3, pp. 504-12, 2009.
C. K. Chan, Ip, M. S., VanVeldhuisen, P. C., Oden, N. L., Scott, I. U., Tolentino, M. J., and Blodi, B. A., SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion., Ophthalmology, vol. 118, no. 7, pp. 1364-72, 2011.
D. V. Weinberg, Wahle, A. E., Ip, M. S., Scott, I. U., VanVeldhuisen, P. C., and Blodi, B. A., Score Study Report 12: Development of venous collaterals in the Score Study., Retina, vol. 33, no. 2, pp. 287-95, 2013.
I. U. Scott, Blodi, B. A., Ip, M. S., VanVeldhuisen, P. C., Oden, N. L., Chan, C. K., and Gonzalez, V., SCORE Study Report 2: Interobserver agreement between investigator and reading center classification of retinal vein occlusion type., Ophthalmology, vol. 116, no. 4, pp. 756-61, 2009.
M. S. Ip, Oden, N. L., Scott, I. U., VanVeldhuisen, P. C., Blodi, B. A., Figueroa, M., Antoszyk, A., and Elman, M., SCORE Study report 3: study design and baseline characteristics., Ophthalmology, vol. 116, no. 9, pp. 1770-1777.e1, 2009.
I. U. Scott, Oden, N. L., VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., and Antoszyk, A. N., SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design., Am J Ophthalmol, vol. 148, no. 5, pp. 725-732.e7, 2009.
A. Hendrick, VanVeldhuisen, P. C., Scott, I. U., King, J., Blodi, B. A., Ip, M. S., Khurana, R. N., and Oden, N. L., SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes With Central or Hemiretinal Vein Occlusion Managed With Aflibercept, Bevacizumab or Observation. Secondary Analysis of the SCORE and SCORE2 Clinical Trials., Am J Ophthalmol, vol. 222, pp. 185-193, 2020.
I. U. Scott, Figueroa, M. J., Oden, N. L., Ip, M. S., Blodi, B. A., and VanVeldhuisen, P. C., SCORE2 Report 5: Vision-Related Function in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion., Am J Ophthalmol, vol. 184, pp. 147-156, 2017.
E. Y. Chew, Clemons, T. E., Sangiovanni, J. Paul, Danis, R. P., Ferris, F. L., Elman, M. J., Antoszyk, A. N., Ruby, A. J., Orth, D., Bressler, S. B., Fish, G. E., Hubbard, G. Baker, Klein, M. L., Chandra, S. R., Blodi, B. A., Domalpally, A., Friberg, T., Wong, W. T., Rosenfeld, P. J., Agrón, E., Toth, C. A., Bernstein, P. S., and Sperduto, R. D., Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3., JAMA Ophthalmol, vol. 132, no. 2, pp. 142-9, 2014.
B. A. Blodi, Domalpally, A., Scott, I. U., Ip, M. S., Oden, N. L., Elledge, J., Warren, K., Altaweel, M. M., Kim, J. E., and Van Veldhuisen, P. C., Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study system for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE Study Report 9., Arch Ophthalmol, vol. 128, no. 9, pp. 1140-5, 2010.
A. Domalpally, Blodi, B. A., Scott, I. U., Ip, M. S., Oden, N. L., Lauer, A. K., and VanVeldhuisen, P. C., The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4., Arch Ophthalmol, vol. 127, no. 11, pp. 1461-7, 2009.